-

AHF Webinar Panel Discussion: Importance of the WHO Pandemic Agreement for Latin America

Wednesday, November 27, 1:00 PM EST Miami, USA, via Zoom

MIAMI--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF), in collaboration with the University of Miami Public Health Policy Lab and the Mexican National Institute of Public Health, will cohost a webinar, "The Importance of the WHO Pandemic Agreement for Latin America,” on Wednesday, November 27, 2024 at 1:00 PM EST, virtually via Zoom. This webinar will be hosted in Spanish, and translation will not be available.

COVID-19 demonstrated that no government or institution can address the threat of future pandemics alone. In a world where infectious diseases are on the rise and readily cross national borders, better preparedness and resilience are essential to combat future global health threats. The World Health Organization Pandemic Agreement, an international legal instrument currently being negotiated by WHO Member States, aims to improve prevention, preparedness, and response to future pandemics on a global scale. This panel brings together leading professionals in the fields of public health and international relations and experts involved in the negotiation process of the Pandemic Agreement to discuss the relevance and importance of the Pandemic Agreement for Latin America.

WHAT:

Webinar: The Importance of the WHO Pandemic Agreement for Latin America*

 

*This webinar will be hosted in Spanish, and translation will not be available.

WHEN:

Wednesday, November 27, 2024

 

TIME:

 

10:00 AM – 11:00 AM Los Angeles

12:00 PM – 1:00 PM Mexico City/Chicago/San José

1:00 PM – 2:00 PM Miami/Bogotá/Lima/Panamá/Quito/Washington, D.C.

2:00 PM – 3:00 PM La Paz

3:00 PM – 4:00 PM Brasilia/Buenos Aires/Santiago

7:00 PM – 8:00 PM Madrid/Geneva

 

WHERE:

Virtual Event via Zoom. Registration Link.

WHO:

EXPERT PANELISTS:

  • Miriam Medel García, M.A. — Head of the Health & Environment Team, Permanent Mission of Mexico to the International Organizations based in Geneva
  • Ricardo Miguel Matute Rojas, D. Eng., M.I.B. — Senior Policy Advocacy Manager, Drugs for Neglected Diseases initiative - DNDi
  • María Juliana Tenorio Quintero, Ph.D., LL.M. — Minister Counselor, Colombian Mission to the United Nations – Geneva

MODERATOR:

  • Jorge Saavedra, M.D., M.P.H., M.Sc. — Executive Director, AHF Global Public Health Institute

NEWS DESK NOTE & B-ROLL VISUALS

Please see attached flyer.

MEDIA CONTACTS:

 

Denys Nazarov, Director of Global Policy & Communications, AHF, +1.323.308.1829, denys.nazarov@ahf.org

 

Brian Shepherd, Associate Director of Global Communications, AHF, +1.808.382.8570, brian.shepherd@ahf.org

 

PANEL OBJECTIVES:

The main objectives of this panel are to identify why the Pandemic Agreement is important for Latin America and to generate constructive dialogue that contributes to the formulation of effective strategies for regional collaboration in Latin America in the prevention and control of pandemics.

AIDS Healthcare Foundation (AHF) is a global non-profit organization providing cutting-edge medicine and advocacy to more than 2 million people in 48 countries worldwide in Africa, the Americas, the Asia/Pacific Region and Europe. We are currently the largest non-profit provider of HIV/AIDS medical care in the world. To learn more about AHF, please visit our website: www.aidshealth.org, find us on Facebook: www.facebook.com/aidshealth and follow us on Twitter: @aidshealthcare and Instagram: @aidshealthcare

The AHF Global Public Health Institute is an initiative of the AIDS Healthcare Foundation created to engage in global public health policy analysis and research to generate objective evidence that can inform improvements in public health policy at the global, regional, national, and local levels, particularly for infectious diseases. To learn more about the AHF Global Public Health Institute, visit https://ahfinstitute.org/.

Contacts

MEDIA CONTACTS:

Denys Nazarov, Director of Global Policy & Communications, AHF, +1.323.308.1829, denys.nazarov@ahf.org
Brian Shepherd, Associate Director of Global Communications, AHF, +1.808.382.8570, brian.shepherd@ahf.org

AIDS Healthcare Foundation


Release Versions

Contacts

MEDIA CONTACTS:

Denys Nazarov, Director of Global Policy & Communications, AHF, +1.323.308.1829, denys.nazarov@ahf.org
Brian Shepherd, Associate Director of Global Communications, AHF, +1.808.382.8570, brian.shepherd@ahf.org

More News From AIDS Healthcare Foundation

Hantavirus Reveals Latin America Is Unprepared, Warns The Lancet Commentary

MEXICO CITY--(BUSINESS WIRE)--The Latin American Technical Working Group, composed of former health ministers from the region, public health experts, epidemiologists, academics, and civil society representatives, published a new comment in The Lancet arguing that Latin America urgently needs a regional rapid-response platform to prevent, prepare for, and respond to infectious threats. Read the full text in The Lancet here. The comment, written collectively by the Technical Working Group, takes...

AHF Welcomes Lula–Tedros Call for Equity in Pandemic Agreement, Warns against Rushing Empty Deal

MIAMI, GENEVA & SÃO PAULO--(BUSINESS WIRE)--The AIDS Healthcare Foundation (AHF) and the AHF Global Public Health Institute welcome the open letter issued by President Luiz Inácio Lula da Silva of Brazil and World Health Organization Director-General Dr. Tedros Adhanom Ghebreyesus on the occasion of the G7 Summit, calling on the leaders of the G7, G20, BRICS, and all nations to finish the Pathogen Access and Benefit-Sharing (PABS) annex of the WHO Pandemic Agreement. AHF particularly commends t...

AHF: Ebola Outbreak Exposes Need for Stronger Investment in Preparedness

KAMPALA, Uganda--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF) calls for stronger investments in Ebola preparedness and response as the current outbreak in the Democratic Republic of the Congo and Uganda underscores the continued threat posed by the deadly disease and the urgent need to strengthen public health systems across Africa. The outbreak is caused by the Bundibugyo virus strain, for which there is currently no approved vaccine or specific treatment. While progress has been made in...
Back to Newsroom